期刊文献+
共找到14篇文章
< 1 >
每页显示 20 50 100
纳米针状Li_(2)MnSiO_(4)正极材料的合成及电化学性能研究
1
作者 李俊鹏 黄妍青 +2 位作者 戴华平 丁正平 任玉荣 《现代化工》 CAS CSCD 北大核心 2024年第1期114-119,共6页
基于Li_(2)MnSiO_(4)结构锂离子迁移的各向异性特征,提出了一种调控材料晶面生长取向的水热合成方法,以提高材料的电化学性能。利用X射线衍射(XRD)、扫描电镜(SEM)、透射电镜(TEM)以及X射线光电子能谱(XPS)等对产物进行表征。结果表明,产... 基于Li_(2)MnSiO_(4)结构锂离子迁移的各向异性特征,提出了一种调控材料晶面生长取向的水热合成方法,以提高材料的电化学性能。利用X射线衍射(XRD)、扫描电镜(SEM)、透射电镜(TEM)以及X射线光电子能谱(XPS)等对产物进行表征。结果表明,产物呈纳米针状(长为200 nm,宽度为30 nm),具有特定晶面暴露的特征。其特殊的纳米结构展现出良好的电化学性能,在0.1 C倍率下,放电比容量达到217.3 mAh/g。 展开更多
关键词 锂离子电池 正极材料 硅酸锰锂 晶面暴露 水热法
下载PDF
基于BIM及有限元的车道区域内支撑拆除施工 被引量:1
2
作者 戴华平 严豪 +2 位作者 周泽志 童富良 陈韬 《智能城市》 2023年第8期126-128,共3页
车道区域的拆除施工采用常规回顶支撑方式无法保证施工安全,且常出现常规运输工具无法运输的情况。中建三局第一建设工程有限责任公司通过技术攻关,成功优化施工方案,总结出适用于车道区域内支撑拆除的关键技术以及适用于同类型车道区... 车道区域的拆除施工采用常规回顶支撑方式无法保证施工安全,且常出现常规运输工具无法运输的情况。中建三局第一建设工程有限责任公司通过技术攻关,成功优化施工方案,总结出适用于车道区域内支撑拆除的关键技术以及适用于同类型车道区域内支撑拆除施工的工法。该工法的推广应用对于解决其他平面楼面板距离内支撑高差回顶支架的拆除提供了一种新的解决方案。 展开更多
关键词 BIM 有限元 内支撑 车道区域
下载PDF
浅析电力系统中配电线路检修技术
3
作者 张忠明 肖书飞 +1 位作者 李红 代华平 《电力系统装备》 2020年第12期150-151,共2页
随着我国经济的不断发展,人们生活水平不断地提高,在此过程中社会和人们对电力资源的需求也变得越来越大。与此同时,电力故障的发生率也在不断增加,所以在此过程中必须要强化线路检修技术。本文就对当前电力系统中配电线路的各种故障进... 随着我国经济的不断发展,人们生活水平不断地提高,在此过程中社会和人们对电力资源的需求也变得越来越大。与此同时,电力故障的发生率也在不断增加,所以在此过程中必须要强化线路检修技术。本文就对当前电力系统中配电线路的各种故障进行分析,然后结合实际情况提出合理地解决措施。 展开更多
关键词 电力系统 配电线路 检修技术
下载PDF
电力系统中配电线路运行故障的检修
4
作者 代华平 余万荣 宋修胜 《电力系统装备》 2019年第7期99-100,共2页
随着经济各方面的不断发展,我国电网也迎来了飞速发展时期。从某程度上来说,国家电网的进步也为社会经济的稳定发展,人们物质生活水平的提高带来诸多推动力。但是从实际情况来看,电力系统配电线路运行中存在的诸多故障问题,不仅降低了... 随着经济各方面的不断发展,我国电网也迎来了飞速发展时期。从某程度上来说,国家电网的进步也为社会经济的稳定发展,人们物质生活水平的提高带来诸多推动力。但是从实际情况来看,电力系统配电线路运行中存在的诸多故障问题,不仅降低了电力行业的整体利益,而且还给用电户造成了诸多不便。本文将以电力系统配电线路故障检修的必要性方面为切入点,重点对其运行的故障以及检修对策展开详细分析,希望能给相关人士提供重要的参考价值。 展开更多
关键词 电力系统 配电线路 故障检修
下载PDF
特发性肺纤维化患者报告结局:健康相关生活质量量表 被引量:2
5
作者 赵锐明 代华平 王辰 《中国实用内科杂志》 CAS CSCD 北大核心 2023年第2期155-158,170,共5页
特发性肺纤维化(idiopathic pulmonary fibrosis,IPF)是一种临床常见的间质性肺疾病(interstitial lung disease,ILD),多见于中老年男性,常表现为进行性肺纤维化及肺组织破坏,伴随肺功能不同程度下降,最终导致呼吸衰竭直至死亡[1-2]。... 特发性肺纤维化(idiopathic pulmonary fibrosis,IPF)是一种临床常见的间质性肺疾病(interstitial lung disease,ILD),多见于中老年男性,常表现为进行性肺纤维化及肺组织破坏,伴随肺功能不同程度下降,最终导致呼吸衰竭直至死亡[1-2]。患者通常会出现咳嗽、呼吸困难、疲劳等对日常生活产生严重影响的症状。同时,作为一种无法治愈的疾病,IPF中位生存期仅2~4年,较差的预后常常使患者背负沉重的心理负担[3]。目前批准上市的药物中,只有尼达尼布与吡非尼酮可以减缓疾病的发展速度,但也无法逆转肺部纤维化进程[4-6]。 展开更多
关键词 特发性肺纤维化 健康相关生活质量 患者报告结局 量表
原文传递
连续性肾脏替代疗法对老年难治性心衰患者多器官的保护作用 被引量:5
6
作者 张颖萍 秦龙 dai hua-ping 《实用老年医学》 CAS 2016年第2期114-117,共4页
目的观察连续性肾脏替代疗法(CRRT)对改善老年难治性心力衰竭(心衰)患者心功能的疗效,以及对肝、肾、肺、脑等多个脏器是否存在保护作用。方法收集我院2009-2014年老年难治性心衰患者(≥60岁)共188例,其中108例仅接受传统治疗,80... 目的观察连续性肾脏替代疗法(CRRT)对改善老年难治性心力衰竭(心衰)患者心功能的疗效,以及对肝、肾、肺、脑等多个脏器是否存在保护作用。方法收集我院2009-2014年老年难治性心衰患者(≥60岁)共188例,其中108例仅接受传统治疗,80例接受传统疗法联合CRRT治疗。传统联合CRRT治疗组在CRRT前(当天)及CRRT后1周分别评估患者心功能、胸部X线、脑电图,以及检验血清天门冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)、血肌酐(SCr)。传统组在相应时间同时行同样评估。结果传统联合CRRT组NYHA心功能分级(P=0.007)、AST(P=0.004)、ALT(P=0.024)、SCr(P=0.046)水平以及脑电异常活动发生率(P=0.037)均较CRRT前下降,而射血分数(EF)值(P=0.019)较CRRT前上升;与传统组比较,其NYHA分级明显改善(P〈0.001),EF值上升(P=0.018),AST(P=0.004)、ALT(P=0.039)、SCr(P=0.032)水平均有所下降,且传统联合CRRT组肺炎(P〈0.001)、脑电活动好转率(P=0.034)均显著高于传统组。结论 CRRT可改善老年难治性心衰患者心功能,并可减少或改善肝、肾、肺、脑等多个器官并发症的出现或损伤程度,对多个器官具有保护作用。 展开更多
关键词 连续性肾脏疗法 难治性心衰 多器官
原文传递
中国特发性肺纤维化患者的直接经济负担 被引量:10
7
作者 宣建伟 卢永吉 +10 位作者 任懋东 张延军 范峰 亢红歌 段晓托 陈荣昌 罗群 韩茜 代华平 谢冰冰 吴逢波 《中国药物经济学》 2019年第6期9-12,共4页
目的评估特发性肺纤维化(idiopathic pulmonary fibrosis, IPF)患者的经济负担,为医疗保险及卫生政策制定提供参考依据。方法基于2013—2017年4家医院的电子医疗病历系统数据,对IPF及相关合并症的直接医疗费用和卫生资源利用情况进行统... 目的评估特发性肺纤维化(idiopathic pulmonary fibrosis, IPF)患者的经济负担,为医疗保险及卫生政策制定提供参考依据。方法基于2013—2017年4家医院的电子医疗病历系统数据,对IPF及相关合并症的直接医疗费用和卫生资源利用情况进行统计分析。患者的纳排标准根据文献检索和IPF临床指南制定。采用描述性统计方法分析患者的经济负担,并将所有费用指标根据医疗卫生类价格指数调整至2017年。结果 4家医院共纳入386例IPF患者,共计562住院例次,人均住院次数为1.5次,患者中位住院费用为12 695元,次均住院时间为10.4 d。IPF合并急性呼吸道事件或其他疾病患者的中位住院费用高于单纯IPF住院患者。结论 IPF患者的经济负担较重,相关合并症或急性加重事件的发生将进一步增加患者的经济负担,需采取有效治疗措施延缓IPF疾病进展,减少相关合并症或急性加重发生,减轻患者的经济负担。 展开更多
关键词 特发性肺纤维化 直接医疗费用 医疗资源利用
原文传递
Prevalence of deep venous thrombosis in patients with acute exacerbation of chronic obstructive pulmonary disease 被引量:24
8
作者 DUAN Sheng-chen YANG Yuan-hua +6 位作者 LI Xu-yan LIANG Xiao-ning GUO Rui-jun XIE Wan-mu KUANG Tu-guang dai hua-ping WANG Chen 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第12期1510-1514,共5页
Background Acute exacerbation of chronic obstructive pulmonary disease (COPD) is always associated with a high incidence and mortality. Because of the presence of some concomitant risk factors such as immobilization... Background Acute exacerbation of chronic obstructive pulmonary disease (COPD) is always associated with a high incidence and mortality. Because of the presence of some concomitant risk factors such as immobilization, bronchial superinfection, patients who are admitted for acute exacerbations of COPD are generally considered to be at moderate risk for the development of venous thromboembolism. In this study, we investigated the prevalence and the clinical manifestations of deep venous thrombosis (DVT) in patients with acute exacerbation of COPD.Methods From March 2007 to March 2009, 520 consecutive patients were included in this study. On admission, color Doppler ultrasound of lower extremities in all cases was performed for diagnosing DVT. Patients with DVT were compared with those without DVT from such aspects as demographics, symptoms, physical signs and risk factors.Results Among the 520 patients, DVT was found in 46 cases (9.7%). In patients with DVT, the duration of hospitalization was longer (P=0.01), and the mechanical ventilation requirement increased (P 〈0.001). Other indicators for patients with more possibility of DVT were immobility exceeding 3 days (P 〈0.001); pneumonia as concomitance (P=0.01); respiratory failure type Ⅱ (P=0.013); current smoking (P=0.001). Lower extremity pain was more common in DVT cases in comparison to those without DVT (34.8% vs. 15.2%, P=0.01 ).Conclusions The acute exacerbation of COPD patients, who were immobilized for over 3 days, complicated by pneumonia and had respiratory failure type Ⅱ, had a higher risk of DVT. In addition, DVT detection awareness should be increased in cases that had a lower extremity pain. 展开更多
关键词 Chronic obstructive pulmonary disease deep venous thrombosis ULTRASONOGRAPHY
原文传递
Idiopathic pulmonary fibrosis in relation to gene polymorphisms of transforming growth factor-β1 and plasminogen activator inhibitor 1 被引量:7
9
作者 LI Xin-xia LI Ning +3 位作者 BAN Cheng-jun ZHU Min XIAO Bai dai hua-ping 《Chinese Medical Journal》 SCIE CAS CSCD 2011年第13期1923-1927,共5页
Background Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal fibrotic lung disease of unknown etiology. Host susceptibility or genetic factors may be important for the predisposition to it. Transformin... Background Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal fibrotic lung disease of unknown etiology. Host susceptibility or genetic factors may be important for the predisposition to it. Transforming growth factor-β1 (TGF-β1 a potent profibrotic cytokine) and plasminogen activator inhibitor 1 (PAl-1) play important roles in the development of pulmonary fibrosis. The objective of the study was to investigate the association between the gene polymorphisms of TGF-β1 869 T〉C and PAl-1 4G/5G and the susceptibility to IPF in Han ethnicity. Methods Polymerase chain reaction (PCR) and restriction fragment length polymorphism were performed to analyse the gene polymorphisms of TGF-β1 in 869T〉C and PAl-1 4G/5G in 85 IPF patients and 85 healthy controls matched in age, gender, race and smoker status. Results There was a significant difference in 869T〉C genotype distribution of TGF-β1 between IPF cases and controls, a significant negative association between TC genotype and the development of IPF (OR=0.508, 95% CI: 0.275-0.941) and a positive association between CC genotype and the development of IPF (OR=1.967, 95% CI: 1.063-3.641). There was a significant positive association between PAl-1 5G/5G genotype and the development of IPF (OR=0.418, 95% CI: 0.193-0.904). Conclusions Gene polymorphisms of TGF-β1 in 869T〉Cand PAl-1 4G/5G may affect the susceptibility to IPF in Han ethnicity. Further investigations are needed to confirm these findings and assess their biological significance in the development of the disease in this ethnic population. 展开更多
关键词 gene polymorphism genetic susceptibility idiopathic pulmonary fibrosis plasminogen activator inhibitor 1 transforming growth factor-beta 1
原文传递
Pneumonia relevant to lung transplantation and pathogen distribution 被引量:7
10
作者 HE Xuan dai hua-ping +10 位作者 CHEN Qi-rui MIAO Jin-bai SUN Bing BAO Na HU Bin LI Hui WU An-shi BAN Cheng-jun GE Su-juan WANG Chen HOU Sheng-cai 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第17期3209-3214,共6页
Background Pneumonia is the most common cause of morbidity and mortality in lung transplant (LT) recipients. The aim of the present study was to evaluate the incidence, etiology, risk factors and prognosis of pneumo... Background Pneumonia is the most common cause of morbidity and mortality in lung transplant (LT) recipients. The aim of the present study was to evaluate the incidence, etiology, risk factors and prognosis of pneumonia in LT recipients. Methods The LT cohort consisted of 28 recipients receiving LT in Beijing Chao-Yang Hospital from August 2005 to April 2011. Data collected included demographic data, underlying disorders, time and type of transplant, follow-up information, date of last follow-up, and patient status. A retrospective analysis was made of observational data that were prospectively collected. Results Twenty-two patients of 28 LT recipients had 47 episodes of pneumonia throughout the study period. Thirty- eight episodes of pneumonia in 19 recipients occurred post-LT with a median follow-up of 257.5 days (1-2104 days), the incidence of pneumonia was 192.4 episodes per 100 LT/year and its median time of onset was 100.5 days (0-946 days) post-transplantation. Bacteria, virus and fungi accounted for 62%, 16% and 15% of the microbial pathogens, respectively. The most frequent were Pseudomonas aeruginosa (20%), cytomegalovirus (CMV) (15%), and Aspergillus fumigatus (10%). A total of 29% (11/38) of pneumonias occurred in the first month post-LT, and then the incidence decreased gradually. The incidence of CMV pneumonia was 25% (7/28) with a median time of 97 days (10-971 days). More than one bacterial infection and CMV infection were independent risk factors for aspergillus infection. The incidence of pulmonary tuberculosis (TB) was 18% (5/28), and the history of TB was a risk factor for TB relapse. There were 58% (7/12) of recipients who died of infection, and 71% (5/7) of these died in the first year after LT. Conclusions Pneumonia is still a major cause of morbidity and mortality in LT recipients. The most frequent microorganisms were Pseudornonas aeruginosa, CMV, and Aspergillus fumigates. The incidence of CMV pneumonia decreases with a delayed median time of onset. More than one incidence of bacterial infection and CMV infection are independent risk factors for aspergillus infection. LT recipients are at high risk for TB, and the history of TB is a risk factor for TB relapse. 展开更多
关键词 lung transplantation PNEUMONIA INFECTION PATHOGEN
原文传递
Recurrent pneumothorax as a presenting manifestation of active sarcoidosis: a case report and literature review 被引量:1
11
作者 LIU Yan dai hua-ping +1 位作者 XU Li-li LI Xue 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第12期1615-1616,共2页
Sarcoidosis is a systemic granulomatous disease of unknown cause. It commonly affects young to middle-aged adults and frequently presents with bilateral hilar lymphadenopathy, pulmonary infiltration, and ocular and sk... Sarcoidosis is a systemic granulomatous disease of unknown cause. It commonly affects young to middle-aged adults and frequently presents with bilateral hilar lymphadenopathy, pulmonary infiltration, and ocular and skin lesions. Pleural involvement is relatively uncommon. Pneumothorax is a rare complication of sarcoidosis, occurring usually in the late fibrotic stages of the disease with associated bullous changes. There are only scattered case reports on pneumothorax as the first manifestation of sarcoidosis in medical literature. The present case study reports a young man who presented first with recurrent spontaneous pneumothorax during the early stage and relapse of sarcoidosis. 展开更多
关键词 GRANULOMAS PNEUMOTHORAX SARCOIDOSIS
原文传递
Clinical features and imaging findings in pulmonary capillary hemangiomatosis: report of two cases and a pooled analysis 被引量:1
12
作者 XIE Wan-mu dai hua-ping +4 位作者 JIN Mu-lan WANG Zhen YANG Yuan-hua ZHAI Zhen-guo WANG Chen 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第17期3069-3073,共5页
Background Pulmonary capillary hemangiomatosis (PCH) is a rare disease and no Chinese case has been reported yet. The disease is often misdiagnosed and its clinical characteristics are incompletely described. The ai... Background Pulmonary capillary hemangiomatosis (PCH) is a rare disease and no Chinese case has been reported yet. The disease is often misdiagnosed and its clinical characteristics are incompletely described. The aim of this study was to describe two Chinese cases and to clarify the clinical and radiographic parameters of patients with PCH. Methods Two PCH cases were presented and other cases were searched from the English literature. All available clinical and radiographic data were collected from 62 literature reported PCH cases. A pooled analysis of total 64 cases was made. Results Dyspnea and hemoptysis were the most common clinical symptoms of PCH. Pulmonary hypertension (PH) was found in 78% of the reported cases. PCH typically showed characteristic diffuse or patchy ground-glass opacities (GGOs) and/or multiple ill-defined centrilobular nodules in the computed tomography. Conclusions The diagnosis of PCH requires a high clinical suspicion. However, both clinical presentations and radiographic studies often provide clues to the diagnosis, which may prompt early lung biopsy for a definite diagnosis. 展开更多
关键词 pulmonary capillary hemangiomatosis pulmonary hypertension lung biopsy
原文传递
Facing the challenges in modern respiratory medicine 被引量:1
13
作者 dai hua-ping SHEN Ying WANG Chen 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第1期3-4,共2页
Respiratory medicine in China has made great .progress in the past decades. Today, modemrespiratory and critical care medicine faces tremendous new challenges and is also provided with greater opportunities. Respirato... Respiratory medicine in China has made great .progress in the past decades. Today, modemrespiratory and critical care medicine faces tremendous new challenges and is also provided with greater opportunities. Respiratory diseases are a leading cause of morbidity and mortality that carry a huge economic and social burden in China. Chronic obstructive pulmonary disease (COPD) alone affects 8.2% of people aged 40 and over; nearly 43 million people in China.1 Respiratory diseases, excluding lung cancer, cor pulmonale and respiratory tuberculosis (TB), are the 4th leading cause of death in China.2 展开更多
原文传递
Wound healing mechanisms and regulation of pulmonary fibrosis: how far are we from the hilltop? 被引量:1
14
作者 XU Xue-feng dai hua-ping WANG Chen 《Chinese Medical Journal》 SCIE CAS CSCD 2011年第24期4125-4126,共2页
L ungs are located in the chest and lie on both sides of mediastinum. The major balance the external and internal function of lung is to ‘gas' environment and to maintain homeostatic equilibrium. Because lung is clo... L ungs are located in the chest and lie on both sides of mediastinum. The major balance the external and internal function of lung is to ‘gas' environment and to maintain homeostatic equilibrium. Because lung is closely interacted with outside surroundings as well as general circulation, it is fair to say that lung is a delicate organ which may be attacked by so many noxious stimuli, 展开更多
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部